SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950103-23-002550
Filing Date
2023-02-17
Accepted
2023-02-17 06:03:33
Documents
1
Group Members
HAN 2020 GRAT

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 dp189092_sc13d-a.htm SC 13D/A 51295
  Complete submission text file 0000950103-23-002550.txt   52639
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Subject) CIK: 0001818838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92270 | Film No.: 23640185
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10179 HUENNEKENS STREET SUITE 103 SAN DIEGO, CA 92121
Business Address
Luo Peter (Filed by) CIK: 0001907614 (see all company filings)

Type: SC 13D/A